Solara Active Pharma Sciences informs about disclosure

30 Aug 2024 Evaluate
Solara Active Pharma Sciences has informed that it enclosed revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August 29, 2024 for Pronomz Ventures LLP.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

535.95 15.55 (2.99%)
22-Jan-2026 13:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1617.25
Dr. Reddys Lab 1216.85
Cipla 1372.40
Zydus Lifesciences 884.55
Lupin 2172.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×